Top Banner
Randox has developed a test for COVID-19 (SARS-CoV-2), the new strain of coronavirus. The only test in the world that can identify the lethal strain and differentiate between other non-lethal variants with the same symptoms. With a global aging population and the increase of inter-linked conditions it is vital to perform comprehensive testing. With the new coronavirus panel available from Randox this will aid the screening and isolation of individuals that require quarantine and immediate intervention, determining positive samples and therefore allowing quick decision making. Six strains of coronavirus including SARS-CoV-2 (SARS-CoV-2, 229E, NL63, OC43, HKUI and MERS- CoV) are detected on this panel. The wider panel provides a more comprehensive respiratory screen enabling informed treatment decisions to be made. The Randox testing method for COVID-19 is a molecular assay based on the detection of the nucleic material (RNA) within the virus. Whereas other testing methods are based on the detection of antibodies which are only produced as a response to the infection, detection of viral RNA allows for the identification of an infection at a much earlier stage since initial exposure. CORONAVIRUS TEST AVAILABLE AT RANDOX VIRUS SARS-CoV-2 (COVID-19) Adenovirus A/B/C/D/E Sarbecovirus (SARS, SARS like, SARS-CoV-2) Enterovirus A/B/C Coronavirus 229E/NL63 Influenza A Coronavirus OC43/HKUI Influenza B Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Rhinovirus A/B
2

CORONAVIRUS · With a global aging population and the increase of inter-linked conditions it is vital to perform comprehensive testing. With the new coronavirus panel available from

Jul 27, 2020

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: CORONAVIRUS · With a global aging population and the increase of inter-linked conditions it is vital to perform comprehensive testing. With the new coronavirus panel available from

Randox has developed a test for COVID-19 (SARS-CoV-2), the new strain of coronavirus.

The only test in the world that can identify the lethal strain and differentiate between other non-lethalvariants with the same symptoms.

With a global aging population and the increase of inter-linked conditions it is vital to perform comprehensive testing. With the new coronavirus panel available from Randox this will aid the screening and isolation of individuals that require quarantine and immediate intervention, determining positive samples and therefore allowing quick decision making.

Six strains of coronavirus including SARS-CoV-2 (SARS-CoV-2, 229E, NL63, OC43, HKUI and MERS-CoV) are detected on this panel. The wider panel provides a more comprehensive respiratory screen enabling informed treatment decisions to be made.

The Randox testing method for COVID-19 is a molecular assay based on the detection of the nucleic material (RNA) within the virus. Whereas other testing methods are based on the detection of antibodies which are only produced as a response to the infection, detection of viral RNA allows for the identification of an infection at a much earlier stage since initial exposure.

CORONAVIRUSTEST AVAILABLE AT RANDOX

VIRUS

SARS-CoV-2 (COVID-19) Adenovirus A/B/C/D/E

Sarbecovirus(SARS, SARS like, SARS-CoV-2)

Enterovirus A/B/C

Coronavirus 229E/NL63 Influenza A

Coronavirus OC43/HKUI Influenza B

Middle East RespiratorySyndrome Coronavirus (MERS-CoV)

Rhinovirus A/B

Page 2: CORONAVIRUS · With a global aging population and the increase of inter-linked conditions it is vital to perform comprehensive testing. With the new coronavirus panel available from

COVID-19 SCREENING KIT: SELF-COLLECT & BACK-TO-LABORATORY ANALYSIS

Using the Randox-patented Biochip Array Technology and the most-comprehensive multiplex PCR platform on the market, the Covid-19 screening kit is available for self-collect testing.

• Suitable for home-based collections or other settings where large scale collections are not required

• Time to result is 3-5 days from receipt of the specimen at the UK laboratory • Detection from a single nasopharyngeal (nose and throat) swab specimen

COVID-19 SCREENING KIT: CONTENTS

• Transportation Box• 1 Swab (A)• 1 Sample Collection Tube (B)• 1 Transportation Tube (C)• 1 Pathoseal Bag (D)• 1 Large Postal Envelope (E)• Sample Collection Instructions• Screening Request Form

A B

CD

E

randoxtestingservices.com [email protected] 028 9445 1011